Business
Published National Findings in Lyme Disease Testing to Be Discussed on July 30 Webinar Hosted by Quidel Corporation
Elizabeth Lee-Lewandrowski, Ph.D., MPH, a national key opinion leader on tick-borne diseases, will discuss the findings of a national seven-year study on Lyme
About this update from Quidelortho Corporation
[{"type":"text","content":"Elizabeth Lee-Lewandrowski, Ph.D., MPH, a national key opinion leader on tick-borne diseases, will discuss the findings of a national seven-year study on Lyme disease testing on a webinar she will be conducting on Thursday, July 30. The webinar is part of an ongoing series hosted by Quidel, the California-based diagnostic healthcare manufacturer known for successfully developing rapid diagnostic health solutions.\nOver the past year, Dr. Lee-Lewandrowski has published two large epidemiological studies documenting changing trends in tick-borne diseases as well as a third paper documenting national trends in non-Lyme disease tick-borne infections. Data from one of these papers was presented to the Health and Human Services Tick-Borne Disease Working Group to assist the group in providing policy guidance to the U.S. government.\nOn the webinar Dr. Lee-Lewandrowski will share the published results of a “national reference laboratory” study on blood-testing for Lyme disease, which she conducted along with her collaborators (https://academic.oup.com/ajcp/article/152/1/91/5461358).\nAmong the findings were that: Lyme disease occurs in all age groups and in all regions of the country; males and females are roughly equally at risk; Lyme disease is seasonal, but a significant number of cases are diagnosed in the winter months; and the demographics of Lyme disease is changing with greater rates of infection in traditionally low-risk states. The study also revealed that Lyme disease is about 10 times more frequent than reported cases to the Centers for Disease Control and Prevention.\nDr. Lee-Lewandrowski is a member of the faculty of the department of pathology at Massachusetts General Hospital in Boston where she also serves as a clinical laboratory scientist in chemistry. She is also assistant professor of pathology at Harvard Medical School. A member of the American Association for Clinical Chemistry, Dr. Lee-Lewandrowski received her Ph.D. in chemistry from Brown University and her master’s in public health from the Harvard School of Public Health. She brings to her July 30 presentation a deep interest in the clinical applications of point-of-care testing technologies that improve outcomes and the efficiency of clinical operations.\nAmong those expected to attend the webinar are physicians, other allied health professionals, scientists...